Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $47.00 at JMP Securities
Cidara Therapeutics (NASDAQ:CDTX – Free Report) had its price target boosted by JMP Securities from $46.00 to $47.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a market outperform rating on the biotechnology company’s stock. Several other equities analysts have also recently weighed in on the company. Citigroup initiated […]
Cidara Therapeutics (NASDAQ:CDTX – Free Report) had its price target boosted by JMP Securities from $46.00 to $47.00 in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a market outperform rating on the biotechnology company’s stock. Several other equities analysts have also recently weighed in on the company. Citigroup initiated […]
